Anzeige
Mehr »
Dienstag, 23.06.2026 - Börsentäglich über 12.000 News
Schuldenfrei, 1,5 Mio. Unzen Gold und Produktion ab 2027: Vor dem Ausbruch?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
168 Leser
Artikel bewerten:
(1)

Revecore Launches ReClaim, an AI-Native Platform Built for the Complexity Modern Hospitals Face

Unified architecture and embedded network intelligence power a new generation of agentic-enabled capabilities, extending Revecore's AI investment across the revenue cycle

FRANKLIN, TN / ACCESS Newswire / June 23, 2026 / Revecore, a leading provider of complex revenue cycle management solutions for hospital systems nationwide, today announced the launch of Revecore ReClaim, an AI-powered revenue recovery intelligence platform and the technology foundation behind every Revecore service. ReClaim builds on the AI-driven underpayment recovery and clinical appeals capabilities announced in April. The platform extends that investment into a unified, AI-native platform purpose-built for the claim types, payer scenarios, and post-adjudication discrepancies standard tools were never designed to handle.

ReClaim arrives as payers accelerate their use of AI and automation to review and deny claims at machine speed, fundamentally changing the recovery environment for hospitals. The share of providers reporting final denial rates above 5% nearly doubled year over year, with hospital executives especially likely to report higher denials. Yet just 2% of revenue cycle organizations report having fully or mostly integrated AI and automation across their RCM operations, leaving a widening gap between what payers are deploying and what most hospitals can respond with.

"The pace of change in payer behavior and reimbursement complexity is unlike anything our clients have faced before," said Noah Breslow, Chief Executive Officer at Revecore. "ReClaim brings together more than two decades of recovery experience with the AI and automation needed to stay ahead of that complexity, not as a replacement for expertise, but as a force multiplier behind it."

A Unified AI-Native Architecture

ReClaim's unified architecture means the same intelligence, automation, and data foundation powers every solution Revecore delivers. Human analysts and AI agents work on the same claims with consistent rules and shared context, allowing new capabilities to be deployed across service lines without fragmenting the underlying logic. The platform is informed by more than 25 years of recovery outcomes across 1,300+ hospitals and a dataset of 750+ million claims, with 15 million added every month, all embedded directly into detection logic, scoring models, and workflows.

Two new capabilities debut with the platform: ReClaim Pulse, which provides 24/7 monitoring of client performance, and ReClaim Connect, which automates connectivity to EHRs, clearinghouses, and payer portals, with seamless integration into Epic, Oracle Health (Cerner), and other major hospital systems.

Extending Revecore's AI Investment

ReClaim's launch extends Revecore's AI strategy into new areas of the revenue cycle. Some recent platform advancements include:

  • Touchless Billing uses direct payer integrations to electronically submit claims and receive acknowledgements in real time, eliminating manual billing steps, reducing billing lag, and accelerating reimbursement timelines.

  • GenAI Medical Record Summarization applies generative AI to extract and summarize key clinical evidence from lengthy medical records, enabling faster, higher-quality appeals and improving revenue recovery outcomes.

  • Agentic AI Workflow Automation leverages AI agents to automate multiple tasks, decisions, and follow-up activities across payer portals, client systems, and internal workflows without manual handoffs, accelerating claim resolution.

"The investments we've made in machine learning, workflow automation, and now agentic and voice-enabled AI all sit on the same platform foundation," said Scott Totman, Chief Technology Officer at Revecore. "That's what this unified architecture makes possible. We can move quickly on new capabilities while keeping every analyst, nurse, and AI agent operating from the same rules, the same data, and the same shared context."

Measurable Client Outcomes

Every AI capability within ReClaim operates under Revecore's human-in-the-loop model, with qualified experts reviewing AI-assisted outputs before any client deliverable or payer submission. The combination of platform intelligence, network learning, and expert review is already producing measurable results:

  • Double-digit year-over-year uplift in underpayment collections

  • 2X+ acceleration in clinical appeal drafting

  • 15-to-20-day reduction in average appeal cycle time versus traditional manual processes

  • Nearly 80% reduction in average days to bill for Revecore's VA service line

For health systems, this translates to more recovered revenue, faster turnaround on the claims that matter most, and clearer visibility into the payer behaviors driving leakage. In a reimbursement environment defined by automation and complexity, ReClaim gives clients a partner whose technology and expertise are evolving even faster than the pressure they face.

About Revecore

Revecore is the proven leader in complex revenue cycle management, trusted by over 1,300 hospitals and health systems nationwide. Purpose-built to master revenue cycle complexity, and informed by decades of operating experience, Revecore combines AI-enabled technology platforms, proprietary claims scoring models, deep clinical and reimbursement expertise, and an outcome-aligned partnership model to deliver outsized financial impact. A six-time Best in KLAS award winner for Complex Claims Services, the company has helped providers recover billions of earned revenue by resolving denials, underpayments, and complex claims at scale. For more information visit www.revecore.com.

Media Contact:

Karina Stabile
Aria Marketing for Revecore
kstabile@ariamarketing.com

SOURCE: Revecore



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/revecore-launches-reclaimtm-an-ai-native-platform-built-for-the-compl-1180382

© 2026 ACCESS Newswire
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.